NYSE · Chemicals - Specialty
CBT (CBT) Stock
$91.75
+2.66%
NYSE: CBT
Basic Materials
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
CBT: What does Argus have to say about CBT?
Argus Research · Jul 15, 2026
Here's Why You Should Retain Cabot Stock in Your Portfolio for Now
Zacks · Jul 14, 2026
Cabot Corporation Board Declares Dividend
GlobeNewswire · Jul 10, 2026
Cabot Corporation to Announce Third Quarter Fiscal 2026 Operating Results
GlobeNewswire · Jul 9, 2026
Is Cabot Corporation (CBT) A Good Stock To Buy Now?
Insider Monkey · Jul 3, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.35%
Institutions Held102.15%
Institutions Float Held103.54%
Peer Comparison
About CBT
CBT stock trades at $91.75 with a market capitalization of $4.74B. The stock is valued at a price-to-earnings (P/E) ratio of 16.74, price-to-book of 2.92, price-to-sales of 1.28. Over the past 52 weeks the stock has ranged between $58.33 and $94.28, and currently trades 2.7% below its 52-week high. It pays a dividend yielding 2.05%.
On profitability, CBT generates a return on equity (ROE) of 19.96%, above the typical market average, return on capital employed of 36.42%, an operating margin of 15.94%, a net profit margin of 7.97%.